123 related articles for article (PubMed ID: 20512841)
41. Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.
Pateras IS; Apostolopoulou K; Koutsami M; Evangelou K; Tsantoulis P; Liloglou T; Nikolaidis G; Sigala F; Kittas C; Field JK; Kotsinas A; Gorgoulis VG
Int J Cancer; 2006 Dec; 119(11):2546-56. PubMed ID: 16988944
[TBL] [Abstract][Full Text] [Related]
42. ANKRD18A as a novel epigenetic regulation gene in lung cancer.
Liu WB; Han F; Jiang X; Yang LJ; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):180-5. PubMed ID: 23131552
[TBL] [Abstract][Full Text] [Related]
43. [Relationship between DNA methylation and expressions of p57kip2 in hepatocellular carcinoma].
Zhao JZ; Zhang ZJ; Shen LJ; Cheng RC; Zhang HX; Qian ZY
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):703-4. PubMed ID: 19785964
[No Abstract] [Full Text] [Related]
44. Epigenetic regulation of ANKRD18B in lung cancer.
Liu WB; Han F; Jiang X; Yin L; Chen HQ; Li YH; Liu Y; Cao J; Liu JY
Mol Carcinog; 2015 Apr; 54(4):312-21. PubMed ID: 24249358
[TBL] [Abstract][Full Text] [Related]
45. TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.
Liu WB; Han F; Jiang X; Chen HQ; Zhao H; Liu Y; Li YH; Huang C; Cao J; Liu JY
Oncotarget; 2015 Aug; 6(25):21225-39. PubMed ID: 26056045
[TBL] [Abstract][Full Text] [Related]
46. [Roles of cyclooxygenase-2 and caspase-3 expression in pathogenesis of lung carcinoma: an experiment with rats].
Chen FC; Pan Q; Zhang YX; Chen HL; Li HG; Tao HC; Yang F; Xia D; Liu MQ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1916-20. PubMed ID: 16255988
[TBL] [Abstract][Full Text] [Related]
47. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
[TBL] [Abstract][Full Text] [Related]
48. Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues.
Azhikina T; Kozlova A; Skvortsov T; Sverdlov E
Cancer Genet; 2011 Sep; 204(9):492-500. PubMed ID: 22018271
[TBL] [Abstract][Full Text] [Related]
49. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.
Shinjo K; Kondo Y
Methods Mol Biol; 2012; 863():221-39. PubMed ID: 22359296
[TBL] [Abstract][Full Text] [Related]
50. Sequential loss of cell cycle checkpoint control contributes to malignant transformation of murine embryonic fibroblasts induced by 20-methylcholanthrene.
Mukherjee S; Manna S; Pal D; Mukherjee P; Panda CK
J Cell Physiol; 2010 Jul; 224(1):49-58. PubMed ID: 20232303
[TBL] [Abstract][Full Text] [Related]
51. [MicroRNA-221 promotes colon carcinoma cell proliferation in vitro by inhibiting CDKN1C/p57 expression].
Sun K; Wang W; Lei ST; Wu CT; Li GX
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1885-9. PubMed ID: 22126772
[TBL] [Abstract][Full Text] [Related]
52. Promoter methylation and enhanced SKP2 are associated with the downregulation of CDKN1C in cervical squamous cell carcinoma.
Roychowdhury A; Pal D; Basu M; Samadder S; Mondal R; Roy A; Roychoudhury S; Panda CK
Cell Signal; 2023 Sep; 109():110735. PubMed ID: 37257769
[TBL] [Abstract][Full Text] [Related]
53. The dual specificity phosphatase 2 gene is hypermethylated in human cancer and regulated by epigenetic mechanisms.
Haag T; Richter AM; Schneider MB; Jiménez AP; Dammann RH
BMC Cancer; 2016 Feb; 16():49. PubMed ID: 26833217
[TBL] [Abstract][Full Text] [Related]
54. Cellular Response upon Stress: p57 Contribution to the Final Outcome.
Rossi MN; Antonangeli F
Mediators Inflamm; 2015; 2015():259325. PubMed ID: 26491224
[TBL] [Abstract][Full Text] [Related]
55. Expression and mutational analysis of Cip/Kip family in early glottic cancer.
Kim DK; Lee JH; Lee OJ; Park CH
J Laryngol Otol; 2015 Feb; 129(2):168-73. PubMed ID: 25695279
[TBL] [Abstract][Full Text] [Related]
56. MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.
Wurz K; Garcia RL; Goff BA; Mitchell PS; Lee JH; Tewari M; Swisher EM
Genes Chromosomes Cancer; 2010 Jul; 49(7):577-84. PubMed ID: 20461750
[TBL] [Abstract][Full Text] [Related]
57. Functional similarities and uniqueness of p27 and p57: insight from a knock-in mouse model.
Susaki E; Nakayama KI
Cell Cycle; 2009 Aug; 8(16):2497-501. PubMed ID: 19597343
[TBL] [Abstract][Full Text] [Related]
58. The cyclin-dependent kinase inhibitor p57(Kip2) is epigenetically regulated in carboplatin resistance and results in collateral sensitivity to the CDK inhibitor seliciclib in ovarian cancer.
Coley HM; Safuwan NA; Chivers P; Papacharalbous E; Giannopoulos T; Butler-Manuel S; Madhuri K; Lovell DP; Crook T
Br J Cancer; 2012 Jan; 106(3):482-9. PubMed ID: 22233925
[TBL] [Abstract][Full Text] [Related]
59. Regulation of p27
Russo GL; Stampone E; Cervellera C; Borriello A
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933137
[TBL] [Abstract][Full Text] [Related]
60. Unmasking the lung cancer epigenome.
Belinsky SA
Annu Rev Physiol; 2015; 77():453-74. PubMed ID: 25668024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
